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Background: Adipose tissue contains a large number of multipotent cells, which are essential for stem cell-based
therapies. The combination of this therapy with suitable commercial clinically used matrices, such as collagen
and elastin matrices (i.e. dermal matrices), is a promising approach for soft tissue reconstruction. We previously
demonstrated that the liposuction method affects the adherence behaviour of freshly isolated adipose-derived
stem/stromal cells (ASCs) on collagen and elastin matrices. However, it remains unclear whether freshly isolated
and uncultured ASCs could be directly transferred to matrices during a single transplantation operation without
additional cell culture steps.
Methods: After each fat harvesting procedure, ASCs were isolated and directly seeded onto collagen and elastin
matrices. Different time intervals (i.e. 1, 3 and 24 h) were investigated to determine the time interval needed for
cellular attachment to the collagen and elastin matrices. Resazurin-based vitality assays were performed after
seeding the cells onto the collagen and elastin matrices. In addition, the adhesion and migration of ASCs on the
collagen and elastin matrices were visualised using histology and two-photon microscopy.
Results: A time-dependent increase in the number of viable ASCs attached to the collagen and elastin matrices
was observed. This finding was supported by mitochondrial activity and histology results. Importantly, the ASCs
attached and adhered to the collagen and elastin matrices after only 1 h of ex vivo enrichment. This finding was
also supported by two-photon microscopy, which revealed the presence and attachment of viable cells on the
upper layer of the construct.
Conclusion: Freshly isolated uncultured ASCs can be safely seeded onto collagen and elastin matrices for ex vivo
cellular enrichment of these constructs after liposuction. Although we observed a significant number of seeded
cells on the matrices after a 3-h enrichment time, we also observed an adequate number of isolated cells after a
1-h enrichment time. However, this approach must be optimised for clinical use. Thus, in vivo studies and clinical
trials are needed to investigate the feasibility of this approach.
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Adipose tissue stores a large number of multipotent
cells, which are essential for stem cell-based therapies
[1]. Stem and progenitor cells typically comprise ap-
proximately 3 to 7% of the cells in the uncultured stro-
mal vascular fraction (SVF) from adipose tissue [1,2].
The term SVF is commonly used in the literature and
refers to the cellular pellet without fat cells (i.e., mature
adipocytes). This fraction can be obtained through an iso-
lation process that uses collagenase secondary to liposuc-
tion (i.e., fat harvesting), resulting in a component that
contains multiple cells: adipose-derived stem/stromal cells
(ASCs). ASCs consist of endothelial cells, smooth muscle
cells, fibroblasts and stem cells. [2]. Adipose-derived stem
cells are adult self-renewing cells of mesenchymal origin
that can differentiate not only into the adipogenic lineage
but also into the osteogenic, chondrogenic, myogenic and
neurogenic lineages in vitro [3,4].
We previously demonstrated that the method of lipo-
suction influences the viability of the ASCs isolated from
adipose tissue and the quantity of growth factors pro-
duced after cellular transplantation onto clinically used
collagen and elastin matrices [5]. The results also indi-
cated that collagen and elastin matrices could be used as
ex vivo cellular carriers for tissue engineering. In this
context, several studies investigated the safety of colla-
gen and elastin matrices for keratinocyte and ASC culti-
vation [6]. Tissue engineering protocols that include a
specific time period for the cultivation of ASCs require
the use of a lab facility for as long as several days. Such
protocols require Good Manufacturing Practicing (GMP)
facilities and may be expensive. In contrast, the manual or
automatic isolation of ASCs can be performed directly
in the operating room (e.g., using a Cytori device).
Thus, the direct transfer of ASCs onto available com-
mercial matrices would be possible during a single op-
eration. However, a short cultivation time (i.e., 1 to
3 hours) would be ideal for transplantation, particularly
in a clinical setting with no access to further lab pro-
cessing or GMP facilities.
The time required for ex vivo attachment of adipose-
derived cells to collagen and elastin matrices before
transplantation of the enriched construct to the patient
during soft tissue reconstruction remains unknown. The
results obtained in our previous study demonstrated that
a significant number of cells attached to the collagen
and elastin matrices after 24 hours of cultivation, regard-
less of the method of liposuction. However, this time is
not realistic for a surgeon performing surgery under an-
aesthesia. Therefore, we compared the enrichment of col-
lagen and elastin matrices with ASCs after short time
periods (i.e., 1 h and 3 h) and long time periods (i.e., 24 h)
to define a protocol that avoids delays in the operating
room (Figure 1).These time intervals were chosen to determine
whether a 3-h time period is needed for cellular sedi-
mentation onto the scaffolds or whether a 1-h sedimen-
tation time is adequate for the cells to attach and
migrate onto the collagen and elastin matrices prior to
transplantation of the enriched construct in the operat-
ing room. We compared the results obtained using short
cultivation times (1 and 3 h) with the results obtained
using a 24-h cellular cultivation time, which was demon-
strated to be a successful approach in our previous study
[5]. We designed the experiment without the need for
processing of the cells to simulate clinical conditions.
Thus, for example, a patient could have a single oper-
ation that included the enrichment of the selected
collagen-based matrix and split thickness skin transfer
for multi-layer reconstruction of soft tissue defects.
Methods
Patients
Ten healthy patients (5 males and 5 females) between 27
and 59 years of age had elective liposuction (i.e., fat har-
vesting) in the Department of Plastic, Reconstructive
and Hand Surgery – Burns Center at RWTH Aachen
University Hospital. Each patient signed the consent
form. The protocol and the use of human material were ap-
proved by the ethics committee of the Faculty of Medicine
at RWTH University in Aachen, Germany (Name in
German: Ethik-Kommission des Universitätsklinikums
Aachen, Votum Number: EK163/07). The experiments
were conducted in compliance with the Declaration of
Helsinki Principles.
Liposuction and centrifugation of the obtained lipoaspirate
Fat was harvested via tumescent liposuction, as de-
scribed previously [5,7]. The harvesting cannula used in
this study was the st’RIM cannula (Thiebaud Biomedical
Devices, Margencel, France), which was developed by
Guy Magalon for micro-lipografting. This cannula was
2 mm in diameter with a blunt tip and four 600-μm
gauge orifices. After the liposuction procedure, the sam-
ples were centrifuged for 3 min at 3,000 rpm using a
Sigma 2–16 K centrifuge (Osterode am Harz, Germany).
After centrifugation, the purified lipoaspirate was imme-
diately used in experiments (Figure 1).
Isolation of ASCs from lipoaspirate
Isolation of the cellular pellet was performed as described
previously [5]. Briefly, the purified lipoaspirate was trans-
ferred into a sterile tube and normal saline was added to
remove cell debris and blood. A second centrifugation
process was then completed for 10 min at 300 × g. The
extracellular matrix was digested with 0.075% collagenase
I (Biochrom, Berlin, Germany) for 45 min at 37°C. The
digested tissue solution was subsequently filtered using a
Figure 1 An illustration of the described approach. After isolation of cells from adipose tissue secondary to liposuction, the obtained
adipose-derived stem/stromal cells were directly transferred to the collagen and elastin matrix without additional cell culture steps. The cells
were incubated on top of the material for different clinically relevant time periods (i.e., 1 and 3 h) for cellular matrix enrichment. For comparison,
the cells were incubated with the matrices for 24 h.
Alharbi et al. BMC Surgery 2014, 14:10 Page 3 of 7
http://www.biomedcentral.com/1471-2482/14/10250 μm filter (Neolab, Heidelberg, Germany). The pellet
was resuspended in 30 ml of a NaCl solution and centri-
fuged for another 10 min at 300 × g to obtain the SVF,
which contained the ASCs. The pellet was then resus-
pended in DMEM/F12 supplemented with 100 U/ml of
penicillin and 100 μg of streptomycin, without foetal calf
serum or proliferation factors. The isolated cells were not
cultured or passaged prior to direct transplantation onto
the collagen and elastin matrix.
Incubation of ASCs on collagen and elastin matrices to
assess cellular adherence
Circular 1 mm thick pieces of non–cross-linked native
bovine collagen and elastin matrix containing type I, III,
and V collagen derived from bovine skin were used
(Matriderm® sheet; MedSkin Solutions Dr. Suwelack AG,
Billerbeck, Germany). A circular punch biopsy device
measuring 0.8 cm in diameter was used to cut the matrix
into small pieces, which were placed into 48-well culture
plates. The isolated cells were added to 48-well culture
plates lined with collagen and elastin matrix at a densityof 50,000 cells per well and incubated at 37°C with 5%
CO2 for 1, 3 or 24 h. The collagen and elastin matrix that
was incubated with the isolated cells was separated after a
1-, 3- or 24-h incubation period (Figure 1). The matrices
were washed carefully with normal saline (0.9% NaCl) and
transferred into a clean culture Plate. A 270 μl volume of
DMEM/F12 supplemented with 100 U/ml penicillin and
100 μg/ml streptomycin was added, and 30 μl of the ala-
marBlue® resazurin reagent (AbD Serotec, Oxford, UK),
was subsequently delivered to each well. This assay can be
used to detect the metabolic activity of cells using a fluor-
escence spectrometer. The medium/alamarBlue® mix was
repeated and carefully removed from the well after 2 hours
at 37°C and 5% CO2. The samples were then measured at
room temperature using a Fluostar Optima fluorescence
spectrometer (BMG Labtech, Offenburg, Germany), with
an excitation wavelength of 540 nm and an emission
wavelength 590 nm. We avoided measuring the matrix it-
self to avoid the influence of the matrix on fluorescence.
The alamarBlue® reagent was added to the medium with-
out cells as a negative control.
Figure 2 Adherence of viable adipose-derived cells onto
collagen and elastin matrices. The box-and-whisker plots display
the fluorescence signals obtained from adhered and viable adipose-
derived cells at different time points (i.e., 1, 3, and 24 h) after seeding
on collagen and elastin matrices, as indicated by the alamarBlue
resazurin-based assay. The bottom and top of the box represent
the first and third quartiles, the band inside the box represents
the median, and the whiskers represent the minimum and the
maximum of the data. All data values are presented in the results
section. Details related to the statistical analysis are presented in the
Methods section. n = 10, *p < 0.05, arbitrary unit; AU.
Alharbi et al. BMC Surgery 2014, 14:10 Page 4 of 7
http://www.biomedcentral.com/1471-2482/14/10Analysis of cellular attachment and migration by histology
Cell-loaded pieces of collagen and elastin matrix were his-
tologically investigated directly after cellular transplant-
ation onto the matrix. The samples were fixed overnight
in Lidi’s 4% formalin (Merck, Darmstadt, Germany). The
formalin was then removed by extensive washing, and the
samples were dehydrated using an increasing gradient of
isopropanol, embedded into paraplast, and cut into 15 μm
sections. Staining was then performed using hematoxylin
and eosin. Microscopic analyses of all samples were per-
formed via light microscopy in our laboratory.
Analysis of cellular distribution on collagen and elastin
matrices using two-photon microscopy
Two-photon microscopy using an FV1000MPE micro-
scope (Olympus Corp., Tokyo, Japan) attached to a
pulsed Ti-Sapphire laser (MaiTai DeepSee, SpectraPhy-
sics, Santa Clara, CA, USA) was performed to visualise
the 3D-structure of the collagen and elastin matrices, in-
cluding the organisation of the isolated cells within the
matrix. Hoechst 33342 was added for vital staining of
the nuclei. The enriched collagen and elastin matrices
were also stained with fluorescein diacetate (FDA) to
image the isolated cells in combination with Hoechst
33342 for nuclei staining. The enriched collagen and
elastin matrix was then visualised using the non-linear op-
tical effect of second harmonic generation (SHG). Hoechst
was excited at 730 nm and detected at 418–468 nm. Series
of subsequent 1024 × 1024 pixel xy-frames were then ob-
tained in 1 mm z-steps for structural 3D reconstruction
using Imaris Software (Bitplane, Zurich, Switzerland).
Statistical analysis
Data analysis was performed using Prism® software, version
5.01c (GraphPad, La Jolla, CA, USA). A Gaussian distribu-
tion of the values was assessed using the D’Agostino &
Pearson omnibus normality test. One-way repeated mea-
sures ANOVA was performed followed by an appropriate
post-hoc multiple comparison test (i.e., Tukey method).
Differences for which p < 0.05 were considered statistically
significant.
Results
Assessment of ASC adherence to collagen and
elastin matrices
The relative viability and adherence rates of the isolated
adipose-derived cells on the collagen and elastin matri-
ces were tested using the alamarBlue-assay® after differ-
ent enrichment times on the matrices (i.e., 1 h, 3 h, and
24 h). A significantly larger number of viable cells were
attached to the collagen and elastin matrices after a 3-h
enrichment time (mean: 1,551 and SD: 790; median:
1615 and range: 284.5-2,972) than after a 1-h incubation
time (mean: 791.4 and SD: 471.3; median: 882.5 andrange: 219.5-1,856) (Figure 2). The observed cellular via-
bility and adhesion rates were 3- to 4-fold higher after a
24-h incubation (mean: 5,120 and SD: 2,070; median:
5,368 and range: 1,267-7,947). However, it should be
noted that freshly isolated uncultured ASCs attached
and adhered to the collagen and elastin matrices after
only 1 h of incubation, indicating that this approach is
clinically relevant.
Analysis of cellular attachment and migration
using histology
Cell-loaded pieces of collagen and elastin matrix were
investigated histologically 1, 3 and 24 hours after seeding
the ASCs onto the matrices. After a 1-h incubation, the
seeded ASCs were observed on the upper layer of the
matrices (Figure 3). Cells that were incubated on the col-
lagen and elastin matrices for 3 h exhibited small cytoplas-
mic fragments deeper in the matrices. ASCs incubated on
the collagen and elastin matrices for 24 hours exhibited
the same migration process into the middle layer.
Visualisation of the 3D structure of collagen and elastin
matrices to assess morphology and attachment of
seeded ASCs
The enriched collagen and elastin matrices were investi-
gated after a 1-h enrichment time via two-photon mi-
croscopy using autofluorescence to reveal the collagen
and elastin structures. Based on the results we obtained
using two-photon microscopy with a 24-h time point in
our previous study [5], we concentrated on early time
Figure 3 Histology of enriched collagen and elastin matrices. This figure shows representative histology images of the collagen and elastin
matrices, which were incubated with freshly isolated adipose-derived stem/stromal cells for the indicated time periods (scale bar is 200 μm).
Figure 4 Two-photon microscopy of the enriched collagen and
elastin matrices. This figure shows a representative two-photon
microscopy image of a collagen and elastin matrix, which was
incubated with freshly isolated adipose-derived stem/stromal cells
for only 1 h. The green colour indicates the cytoplasm of viable cells,
which was stained using fluorescein diacetate (FDA), the blue colour
indicates the cell nuclei, which were stained using Hoechst 33342,
and the grey colour indicates the collagen and elastin structure
(scale bar is 100 μm).
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were observed on the 3D structure of the collagen and
elastin matrix (Figure 4). The previously discussed meta-
bolic activity tests and histological investigations demon-
strated that a number of isolated cells attached to the
collagen and elastin matrices after 1 h. The green colour
indicates the cytoplasmic portion of cells, which was
stained with FDA, and the blue colour shows the nuclei,
which were stained with Hoechst 33342. The spatial dis-
tribution of the cells is also shown (Figure 4).
Discussion
The clinical applicability of adipose-derived stem cell
therapy has been investigated extensively during the last
decade, and interesting results have been obtained with
respect to regeneration and wound healing, as well as re-
construction and rejuvenation [4]. One advantage of this
approach is that adipose tissue represents an easily avail-
able and accessible source of mesenchymal stem cells
that are supported by abundant stromal cells and growth
factors [5]. However, it is essential to determine the ap-
plicability of this approach, particularly with respect to
legal issues. In some countries, including Germany, any
patient materials that leave the operating room for stem
cell processing and future re-injection must be processed
in GMP facilities. These facilities are expensive and diffi-
cult to find. In contrast, autologous transplantation of
ASCs in a single session would overcome this problem.
Several previous studies investigated the effect of enrich-
ing fat grafts with the SVF in a clinical setting [8]. How-
ever, it remains unclear whether the enrichment of a
safe and biocompatible collagen and elastin matrix with
autologous and freshly isolated ASCs is possible. In
addition, the role of enrichment time in this approach
has not been investigated. Studies addressing these is-
sues could expand the use of soft tissue matrices in
combination with ASCs.Biocompatible matrices, such as collagen and elastin
matrices, are currently used in combination with skin
grafting as double-layer constructs to support the graft
and the formation of a neodermis [9]. However, it must
be determined not only whether such matrices are bio-
compatible but also whether they are cytocompatible. In
our previously published study, we demonstrated that
freshly isolated uncultured ASCs adhere to collagen and
elastin matrices ex vivo in only 24 hours. This result
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cytocompatible and appropriate for use with mesenchy-
mal stem cells immediately after their isolation.
However, a 24-h enrichment time is too long to be im-
plemented in the operating room. Thus, a shorter en-
richment time of the selected scaffolds with the stem
cells is required. We investigated different time intervals
to determine whether a 3-h or 1-h cellular sedimenta-
tion time on the scaffolds is sufficient to support cellular
attachment and migration onto the collagen and elastin
matrices prior to transplantation of the enriched con-
struct in the operating room. We compared the results
obtained using these short cultivation times (i.e., 1 and
3 h) with the results obtained using a 24 h cellular culti-
vation time.
In this study, we observed that cellular enrichment on
the collagen and elastin matrices after 3 h is improved
compared to that observed after 1 h. These results were
supported by mitochondrial activity results, which indi-
cate viability, and histological analysis [10-13]. In
addition, we demonstrated that enrichment of a collagen
and elastin matrix with cells obtained from adipose tis-
sue is possible after a 1-h ex vivo enrichment time. This
conclusion was also supported by two-photon micros-
copy results, which revealed the presence and attach-
ment of viable cells on the upper layer of the construct.
However, penetration depth is limited based on the
employed material, tissue or scaffold (e.g., for collagen
and elastin matrices up to 150 μm).
Protocols must be defined for clinical use. Such proto-
cols should include the ideal time for cellular enrich-
ment on the selected biocompatible and cytocompatible
matrices, the number of isolated adipose cells per square
meter, the proportions of specific cellular elements, in-
cluding stem cells, in the total population, the commit-
ment of those stem cells toward adipogenic conversion
or conversion into other lines in vivo and the factors im-
portant for control of the environment, including factors
that support nutrition and angiogenesis. These factors
must be investigated in animal models before this type
of therapy can be applied in a clinical setting. The fate
of ASC-enriched collagen and elastin matrices after
transplantation can only be determined in vivo in clin-
ical trials. However, prior to clinical trials, it is also ne-
cessary to optimise this approach. Specifically, the type
of isolated cells that adhere to the matrix must be char-
acterised. The regenerative potential of these cells and
the potential benefits for patients should also be ad-
dressed in future studies. As previously discussed, the
use of the freshly isolated uncultured ASCs seeded dir-
ectly onto biocompatible scaffolds during a single sur-
gery avoids the need for GMP facilities. Thus, this
approach would bridge the gap between the bench and
the bedside.Conclusion
Freshly isolated uncultured ASCs can be safely seeded
onto collagen and elastin matrices after a liposuction
procedure for ex vivo cellular enrichment of these con-
structs. Although we observed a significant number of
transplanted cells on the matrices after a 3-h enrichment
time, we could also observed an adequate number of iso-
lated cells on the matrices after a shorter 1-h enrich-
ment time. This finding was also supported by two-
photon microscopy. However, it is necessary to optimise
this approach for clinical use. Thus, in vivo studies and
clinical trials are needed to investigate the feasibility of
this approach.
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